
10/08/2025
Samir Parekh, MD, discusses managing a rare case of T-cell lymphoma following BCMA CAR T-cell therapy, and how a CCR4-targeted strategy achieved a durable remission, highlighting the importance of personalized, mechanism-based approaches in post–CAR T-cell care.
Samir Parekh, MD, discusses managing a rare T-cell lymphoma post BCMA CAR T-cell therapy and how CCR4-targeted treatment achieved durable remission.